a brief background of the indian pharmaceutical industry

TOP 10 PHARMA COMPANIES IN INDIA 2015

A BRIEF BACKGROUND OF THE INDIAN PHARMACEUTICAL INDUSTRY

The Indian pharmaceuticals market is third largest in terms of volume and thirteen largest in terms of value, as per a pharmaceuticals sector analysis report by equity master. The Indian pharmaceutical industry is estimated to grow at 20 per cent compound annual growth rate (CAGR) over the next five years, as per India Ratings, a Fitch Group company. We expect the domestic Pharma market to grow at 10-12 per cent in FY15 as compared to 9 per cent in FY14, as per a recent report from Centrum Broking. The Union Cabinet has given its approval to amend the existing FDI policy in the pharmaceutical sector in order to cover medical devices. The Cabinet has allowed FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to specified conditions. The Indian pharma market size is expected to grow to US$ 85 billion by 2020. The growth in Indian domestic market will be on back of increasing consumer spending, rapid urbanisation, raising healthcare insurance and so on.Going forward, better growth in domestic sales will depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers are on the rise.

LIST OF 17 PHARMACEUTICAL GIANTS OF INDIA CONSIDERED FOR THE TOP 10 POSITIONS

Method of Ranking:Based on simple revenue values I sorted out the top 17 Pharmaceutical companies of India. Followed by that gathered data of Table 1 from Moneycontrol.com, Forbes2000, Companys Annual Reports, Google Market Cap Data and also used the official patent list provided by Indian Patent Office (The link is provided above in the table 1).I have incorporated the following parameters while ranking the Companies1. Financial performanceMarket Capitalization

2. Value perceived by share holders3. Consistency in PerformanceRevenue

4. Net Revenue5. Profit being madeProfit

6. And innovation/extent of research No. of Patents

and developmentWhile doing the final ranking I allotted the following weightages to the above discussed parameters to determine a consolidated ranking indexMarket Capitalization30%

Revenue40%

Profit10%

Patents in their name20%

And the calculation helped me to generate the list of THE TOP 10 PHARMACEUTICAL COMPANIES OF INDIA .And Here we go with detailed list.

#10 IPCA LABORATORIES :Ipca Laboratoriesis an international pharmaceutical company based in Mumbai, India. It is also one of the largest suppliers of these APIs and their intermediates world over. The various products of the company include formulations, drug intermediates, andActive Pharmaceutical Ingredients(API). It was founded by group of businessmen and medical professionals in 1949.In 1975, the management of the company was taken over by Amitabh Bachchan, Ajitabh Bachchan, Jaya Bachchan, M.R. Chandurkar, P.C. Godha. IPCA isevolving rapidly. Their stature as a pharmaceutical company that partners healthcare globally,while being driven by quality, continues to grow with each passing day. Their brand identity asevolvedtoo.Modern,dynamic yet warm and friendly,energetic yet sensitive, Their new identity is an expression of the IPCA of today... an organization that works asequal partnerswith global pharmaceutical leaders.Ipca manufactures over 350 formulations in virtually every dosage form: oral solids and liquids, dry powders for suspension, and injectables (liquid and dry). Their renowned products are Zerodol, Lariago, Perinorm, Etova, Folitrax, Malirid etc. THE FACT SHEETRevenuesINR. 3234.82Crores

Market CapitalizationINR. 8400.44Crores

ProfitINR. 477.34Crores

Total No. of Patents in their name10

Consolidated Ranking Index3863.797

#09 WOCKHARDT:

Wockhardt, headquartered inMumbai, India, is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is Indias leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Wockhardt was founded by Habil Khorakiwala in the early 1960s.His fatherFakhruddin T. Khorakiwalahad acquiredWorli Chemical Worksin 1959. Wockhardt works with partners to in-license products in India and out-license products into other regions by capitalising on these collaborative strengths to capture and penetrate new markets.Their most renowned brands are Aceroc, Ace Proxyvon, Biovac-B, Brozedex, Cavidin INH etc. THE FACT SHEETRevenuesINR. 1805.27Crores





#08 TORRENT PHARMACEUTICALS LTD:

Torrent Pharmaceuticals Ltd.is the flagship company of theTorrent Group. Based inAhmedabad, it was promoted byU. N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name Torrent Pharmaceuticals Ltd.Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally. The company's key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs.Moreover, it has 7 fully owned subsidiaries:1. Heumann Pharma GmbH & Co Generica KG,Germany2. Torrent Pharma GmbH,Germany3. Torrent do Brasil Ltda.,Brazil4. ZAO Torrent Pharma,Russia5. Torrent Pharma Inc.,United States6. Torrent Pharma Philippines Inc.,Philippines7. Torrent Pharma Canada Inc.,CanadaTorrent Pharmaceuticals acquired Heumann GmbH, a Pfizer group company in 2005.Some of the renowned products of them are Nicorandil, Risperidone, Lamotrigine, Esomeprazole Sodium etc. THE FACT SHEETRevenuesINR. 3364.87Crores





#07 GLAXOSMITHKLINE PHARMACEUTICALS LTD:

Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer. This mission drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions.The GSK India product portfolio includes prescription medicines and vaccines. Our prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.Their product portfolio includes Calpol, Neosporin-H ointment, Phexin, Zovirax, Benitec, Carzek, Hiberix, Havrix etc.THE FACT SHEETRevenuesINR. 2546.15Crores





#06 CADILA PHARMACEUTICALS:Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last six decades, the company has been developing and manufacturing pharmaceutical productsin India and selling and distributing these in over eighty-five other countries around the world.Focused strongly on Innovation and Research, the company is present in more than forty-five therapeutic areas spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.At Cadila Pharmaceuticals, Research and Development is at the core of all its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture or Phytochemistry.The company has strong foothold in the African continent through its formulation manufacturing facility at Addis Ababa in Ethiopia.Their extensive range of finished dosageformulationscovers every aspect of human life. Their basket of formulations contain more than 850 products in several forms belonging to 45 therapeutic segments and 12 specialities including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics, immunogicals and oncology.Some of the well-known brands of them are Acenext, Cadicoff, Exenot, Eplecard, Glista etc.THE FACT SHEETRevenuesINR. 9380.29Crores





#05 AUROBINDO PHARMA:

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such asneurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.Through cost effective manufacturing capabilities and a few loyal customers, the company entered the high margin specialty generic formulations segment. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries. It aims to achieve USD 2 billion revenues by 2015-16. Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.Its best known brands are Aurox, Cedbrox, Tripcut, Cefactam, ProxtL, AxtL, Recipro, Diceta etc.THE FACT SHEETRevenuesINR. 9380.29Crores





#04 CIPLA:

Ciplaisa global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Ciplas mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients.It was incorporated in the year of 1935. Headquartered at Mumbai,India ,with an employee base of 20000+ Cipla focuses on continuous innovation in R &D with 30+world firsts. Its product portfolio includes over 1,500 products across varioustherapeutic categories, with 60+dosage forms. It has a remarkable presence in over 150 countries.It has International Approvals from US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among othersSome of its revolutionary brands are Acarboze, Natamycin,Terazocin, Ciclesonide etcTHE FACT SHEETRevenuesINR. 7110.71Crores





#03 DR. REDDYS LABORATORIES LTD:

Dr. Reddy's Laboratories, is a multinational pharmaceutical company based inHyderabad,Telangana, India. The company was founded byAnji Reddy. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60active pharmaceutical ingredients(APIs) for drug manufacture, diagnostic kits,critical care, andbiotechnologyproducts. In 2014, Dr. Reddy Laboratories was listed among 1200 of India's most trusted brands according to theBrand Trust Report2014.Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets to gain approval from a drug licensing body such as theU.S. Food and Drug Administration(FDA). By 2007, Dr. Reddy's had six FDA plants producing active pharmaceutical ingredients in India and seven FDA-inspected andISO 9001(quality) andISO 14001(environmental management) certified plants making patient-ready medications five of them in India and two in the UK.Some of their best-selling brands are Allopurinol tablets, Ciprofloxacin Tablets, Clopidogrel Tablets, Famotidine Tablets, Fluoxetine Capsules etc.THE FACT SHEETRevenuesINR. 9993.9Crores





#02 LUPIN PHARMACEUTICALS, Inc:

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited.Through sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.Lupin Limited, headquartered in Mumbai, India, is strongly research focused. It has a program for developing New Chemical Entities. The company has a state-of-the-art R&D center in Pune and is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs (ACE-inhibitors and cholesterol reducing agents) and has a notable presence in the areas of diabetes, anti-inflammatory and respiratory therapy.It has the distinction of being the fastest growing generic pharmaceutical player in the two largest pharmaceutical markets of the world theUSandJapan;and is the 4th largest and the fastest growing generic pharmaceutical player inSouth Africa. Lupins research program covers the entire pharma value chain. The companys global R&D program is headquartered in the Lupin Research Park located near Pune that houses over 1400 scientists.Some of its well-recognized brands are Norvasc, Trizivir, Creftin. Lexapro, Mevacor, Pravacol etc. THE FACT SHEETRevenuesINR. 8939.38Crores





#01 SUN PHARMACEUTICAL INDUSTRIES LTD:

Sun Pharmaceutical Industries Limited is a multinationalpharmaceuticalcompany headquartered inVadodara, Gujaratthat manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such ascardiology,psychiatry,neurology,gastroenterologyanddiabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances.Sun Pharmaceuticals was established by Mr.Dilip Shanghviin 1983 inVapiwith five products to treatpsychiatryailments. Cardiology products were introduced in 1987 followed bygastroenterologyproducts in 1989. Today it is the largest chronic prescription company in India and a market leader inpsychiatry, neurology, cardiology,orthopedics,ophthalmology, gastroenterology andnephrology.The 2014 acquisition ofRanbaxywill make the company the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest speciality generic company globally.Some of its best-selling products are Adcapone, Alzolam, Angizem, Aztor etc.THE FACT SHEETRevenuesINR. 2828.79Crores


ProfitINR. -2828.52Crores



a brief background of the indian pharmaceutical industry

Documents

indian pharmaceutical

pharmaceutical sector

pharmaceutical giants

indian domestic market

indian pharmaceuticals

indian pharma market

domestic pharma market

india ratings